FIRST AMENDMENT TO THE EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 8th, 2015 • Cancer Prevention Pharmaceuticals, Inc. • Pharmaceutical preparations
This first amendment (“Amendment”) to the Amended and Restated Exclusive License Agreement between The Arizona Board of Regents on behalf of The University of Arizona, with its principal offices in Tucson, Arizona 85721 ("ARIZONA") and Cancer Prevention Pharmaceuticals, Inc. an Delaware Corporation with its principal place of business at 1760 E. River Rd., Suite 250, Tucson, AZ 85718 ("LICENSEE") is made effective on the date of the last authorized signature below (“Amendment Effective Date”).
